Page last updated: 2024-09-03

cp 93129 and Dyskinesia Syndromes

cp 93129 has been researched along with Dyskinesia Syndromes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Atack, J; Chadha, A; Duty, S; Sur, C	1

Other Studies

1 other study(ies) available for cp 93129 and Dyskinesia Syndromes

Article	Year
The 5HT(1B) receptor agonist, CP-93129, inhibits [(3)H]-GABA release from rat globus pallidus slices and reverses akinesia following intrapallidal injection in the reserpine-treated rat. British journal of pharmacology, 2000, Volume: 130, Issue:8 Topics: Animals; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Globus Pallidus; In Vitro Techniques; Male; Movement Disorders; Propanolamines; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Reserpine; Serotonin Antagonists; Serotonin Receptor Agonists; Tritium	2000

Article

Year

The 5HT(1B) receptor agonist, CP-93129, inhibits [(3)H]-GABA release from rat globus pallidus slices and reverses akinesia following intrapallidal injection in the reserpine-treated rat.

British journal of pharmacology, 2000, Volume: 130, Issue:8

Topics: Animals; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Globus Pallidus; In Vitro Techniques; Male; Movement Disorders; Propanolamines; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Reserpine; Serotonin Antagonists; Serotonin Receptor Agonists; Tritium

2000